Fundraising FoxIU Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Adipo Therapeuticsadipotherapeutics.cominJan 2024
Adipo develops investigational therapeutics that promote weight loss by activating brown fat to increase energy expenditure, offering an alternative to appetite-suppressing drugs like GLP-1s.
BiotechHealthtechLongevityIndianapolis, US
Keith Johns(Executive Officer)inKaren Wurster(Executive Officer, Director)inMeng Deng(Director)
BoardMichael Clayman(Director)
Co-investorsElevate VenturesOkeanosRiverbend Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.